Purchase Order 36C25026P0274
- Not listed
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a purchase order valued at $5.17 million by the Department of Veterans Affairs' Veterans Integrated Service Network 8 on October 1, 2022. This firm fixed-price contract, with no set-aside designation, is a modification to an existing agreement that adjusts clinical quantities based on updated workload estimates for microbiology testing services. The contract calls for an all-inclusive...
- The Department of Veterans Affairs Veterans Integrated Service Network 5 (VA Maryland Health Care System) awarded a purchase order contract to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, for PCR test kits and supplies compatible with Cepheid GeneXpert instruments. The contract, valued at $214,641.72 with a firm fixed-price structure, covers a one-year period from December 1, 2025 through November 30, 2026. The procurement encompasses five...
- This firm fixed-price purchase order, valued at $386,484.18, was awarded by the Department of Veterans Affairs (VA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract, which has an ultimate completion date of September 30, 2025, is for the provision of GeneXpert 48-48 diagnostic systems, reagents, test kits, and associated maintenance services. These solutions enable rapid detection and diagnosis of infectious diseases such...
- The Department of Veterans Affairs' Veterans Integrated Service Network 20 awarded a $112,775 firm fixed-price purchase order to Cepheid Inc. for GeneXpert analyzer services with an ultimate completion date of February 4, 2030. The contract, which carries no set-aside designation, will be performed in Spokane, Washington. Cepheid is a Sunnyvale, California-based manufacturer specializing in molecular diagnostic solutions, particularly GeneXpert diagnostic systems and associated reagents designed...
- The Department of Veterans Affairs, Veterans Integrated Service Network 10, awarded a $192,866.10 firm fixed-price purchase order to Cepheid Inc. for reagents with an ultimate completion date of February 28, 2026. The contract, which carries no set-aside designation, involves the addition of two line items to support molecular diagnostic testing capabilities. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic solutions, will deliver these reagents to the...
- The Department of Veterans Affairs, Veterans Integrated Service Network 9, awarded a delivery order valued at $168,685.49 to Cepheid Inc. for Cepheid reagents for patient testing, effective November 1, 2025, with an ultimate completion date of September 30, 2026. This firm fixed-price delivery order carries no set-aside designation and represents a reconnection of funding and procurement routing to support continued reagent delivery under an existing vehicle. Cepheid, a for-profit molecular...
- The Department of Veterans Affairs, Veterans Integrated Service Network 4, awarded a delivery order valued at $187,294.70 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for the provision of test kits. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for completion by September 20, 2026, and will be performed in Coatesville, Pennsylvania. Cepheid specializes in GeneXpert diagnostic systems and associated molecular...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $148,635.00 firm fixed price purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the delivery of GENEXPERT XVI R2 16 diagnostic testing equipment and related consumables. The contract has a completion date of June 26, 2023. Cepheid is a prime contractor that has received numerous awards from federal agencies, including the VA, Defense Logistics Agency, and Department of Health...
- The Department of Veterans Affairs' Veterans Integrated Service Network 17 awarded a firm fixed-price definitive contract to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, with a ceiling value of $5.33M. This is the third option year of the REGENTS contract, with an ultimate completion date of January 24, 2028. The award was made on January 25, 2023, with no set-aside designation. Cepheid specializes in advanced diagnostic systems and test kits, including...
- The Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a purchase order to Cepheid Inc. (Sunnyvale, CA) on December 1, 2023, for reagents and consumables supporting the Puget Sound VA Medical Center. This firm fixed-price contract carries a ceiling value of $830,637 and was completed by November 30, 2024. The award represents a continuation of the VA's reliance on Cepheid's molecular diagnostic solutions, which are integral to clinical laboratory operations across...
The Department of Veterans Affairs' Veterans Integrated Service Network 10 awarded a $79,343.96 firm fixed-price purchase order to Cepheid Inc. for GeneXpert diagnostic supplies effective January 1, 2026 with completion by March 31, 2026. Cepheid, a molecular diagnostics manufacturer headquartered in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for detecting infectious diseases and other medical conditions. This purchase order represents a routine procurement transaction for diagnostic reagents and supplies to support clinical laboratory operations across the VA's healthcare network. This award carries no set-aside designation and reflects Cepheid's established role as a primary supplier of molecular diagnostic solutions to the VA system. The company maintains substantial underlying contract vehicles with VA networks, including a $32.8 million indefinite delivery contract with Veterans Integrated Service Network 6 that runs through September 30, 2030, and a $2.5 million IDV with Veterans Integrated Service Network 21 for PCR testing and laboratory microbiology services. The current purchase order likely draws from one of these existing delivery order contracts, enabling the VA to procure GeneXpert supplies—which support testing for COVID-19, influenza, respiratory syncytial virus, and other infectious diseases—on an as-needed basis to maintain diagnostic capabilities across VA medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $79.3k | 1/2/26 |